PROM1 and neoplasm: However, the tumor-initiation ability of α2δ1+ cells is the highest among these population (Fig. 3F, Supplementary Table 5), indicating that α2δ1 is the most robust marker for enriching NSCLC TICs compared with CD133 and CD166.